| Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing BW Kunkle, B Grenier-Boley, R Sims, JC Bis, V Damotte, AC Naj, ... Nature genetics 51 (3), 414-430, 2019 | 2306 | 2019 |
| Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease R Sims, SJ Van Der Lee, AC Naj, C Bellenguez, N Badarinarayan, ... Nature genetics 49 (9), 1373-1384, 2017 | 932 | 2017 |
| Human whole genome genotype and transcriptome data for Alzheimer’s and other neurodegenerative diseases M Allen, MM Carrasquillo, C Funk, BD Heavner, F Zou, CS Younkin, ... Scientific data 3 (1), 1-10, 2016 | 366 | 2016 |
| Brain expression genome-wide association study (eGWAS) identifies human disease-associated variants F Zou, HS Chai, CS Younkin, M Allen, J Crook, VS Pankratz, ... PLoS genetics 8 (6), e1002707, 2012 | 253 | 2012 |
| Meta-analysis of the Alzheimer’s disease human brain transcriptome and functional dissection in mouse models YW Wan, R Al-Ouran, CG Mangleburg, TM Perumal, TV Lee, K Allison, ... Cell reports 32 (2), 2020 | 218 | 2020 |
| Novel late-onset Alzheimer disease loci variants associate with brain gene expression M Allen, F Zou, HS Chai, CS Younkin, J Crook, VS Pankratz, ... Neurology 79 (3), 221-228, 2012 | 177 | 2012 |
| Association of MAPT haplotypes with Alzheimer’s disease risk and MAPT brain gene expression levels M Allen, M Kachadoorian, Z Quicksall, F Zou, HS Chai, C Younkin, ... Alzheimer's research & therapy 6, 1-14, 2014 | 154 | 2014 |
| Conserved brain myelination networks are altered in Alzheimer's and other neurodegenerative diseases M Allen, X Wang, JD Burgess, J Watzlawik, DJ Serie, CS Younkin, ... Alzheimer's & dementia 14 (3), 352-366, 2018 | 124 | 2018 |
| Late-onset Alzheimer’s risk variants in memory decline, incident mild cognitive impairment, and Alzheimer’s disease MM Carrasquillo, JE Crook, O Pedraza, CS Thomas, VS Pankratz, M Allen, ... Neurobiology of aging 36 (1), 60-67, 2015 | 119 | 2015 |
| Genetic variants in a haplotype block spanning IDE are significantly associated with plasma Aβ42 levels and risk for Alzheimer disease N ErtekinTaner, M Allen, D Fadale, L Scanlin, L Younkin, RC Petersen, ... Human mutation 23 (4), 334-342, 2004 | 112 | 2004 |
| A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the … SJ Van Der Lee, OJ Conway, I Jansen, MM Carrasquillo, L Kleineidam, ... Acta neuropathologica 138, 237-250, 2019 | 111 | 2019 |
| Glutathione S-transferase omega genes in Alzheimer and Parkinson disease risk, age-at-diagnosis and brain gene expression: an association study with mechanistic implications M Allen, F Zou, HS Chai, CS Younkin, R Miles, AA Nair, JE Crook, ... Molecular neurodegeneration 7, 1-12, 2012 | 100 | 2012 |
| Large eQTL meta-analysis reveals differing patterns between cerebral cortical and cerebellar brain regions SK Sieberts, TM Perumal, MM Carrasquillo, M Allen, JS Reddy, ... Scientific data 7 (1), 340, 2020 | 88 | 2020 |
| ABI3 and PLCG2 missense variants as risk factors for neurodegenerative diseases in Caucasians and African Americans OJ Conway, MM Carrasquillo, X Wang, JM Bredenberg, JS Reddy, ... Molecular neurodegeneration 13, 1-12, 2018 | 88 | 2018 |
| Linkage, whole genome sequence, and biological data implicate variants in RAB10 in Alzheimer’s disease resilience PG Ridge, CM Karch, S Hsu, I Arano, CC Teerlink, MTW Ebbert, ... Genome medicine 9, 1-14, 2017 | 78 | 2017 |
| Late-onset Alzheimer disease risk variants mark brain regulatory loci M Allen, M Kachadoorian, MM Carrasquillo, A Karhade, L Manly, ... Neurology: Genetics 1 (2), e15, 2015 | 74 | 2015 |
| Expression and processing analyses of wild type and p. R47H TREM2 variant in Alzheimer’s disease brains L Ma, M Allen, N Sakae, N Ertekin-Taner, NR Graff-Radford, DW Dickson, ... Molecular neurodegeneration 11, 1-9, 2016 | 71 | 2016 |
| Investigation of 15 of the top candidate genes for late-onset Alzheimer’s disease O Belbin, MM Carrasquillo, M Crump, OJ Culley, TA Hunter, L Ma, ... Human genetics 129, 273-282, 2011 | 70 | 2011 |
| Concordant Association of Insulin Degrading Enzyme Gene (IDE) Variants with IDE mRNA, Aß, and Alzheimer's Disease MM Carrasquillo, O Belbin, F Zou, M Allen, N Ertekin-Taner, M Ansari, ... PloS one 5 (1), e8764, 2010 | 69 | 2010 |
| TLR5 decoy receptor as a novel anti-amyloid therapeutic for Alzheimer’s disease P Chakrabarty, A Li, TB Ladd, MR Strickland, EJ Koller, JD Burgess, ... Journal of Experimental Medicine 215 (9), 2247-2264, 2018 | 57 | 2018 |
